Characterization of a spliced variant of human IRF-3 promoter and its regulation by the transcription factor Sp1

Molecular Biology Reports

Volumn 39, Issue 6, 2012, Pages 6987-6993

  Ren, Wei ^a   Zhu, Liang Hua ^a   Xu, Hua Guo ^a   Jin, Rui ^a   Zhou, Guo Ping ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Interferon regulatory factor 3 (IRF 3); IRF 3 promoter; Sp1 transcription factor; Spliced variant; Transcriptional activity

Indexed keywords

INTERFERON REGULATORY FACTOR 3; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA FLANKING REGION; GENE DELETION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION;

5' FLANKING REGION; BASE SEQUENCE; BINDING SITES; GATA1 TRANSCRIPTION FACTOR; GENES, REPORTER; HEK293 CELLS; HELA CELLS; HUMANS; INTERFERON REGULATORY FACTOR-3; LUCIFERASES; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN ISOFORMS; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84864289049     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1528-9     Document Type: Article

References (34)

1. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N (2001) IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19:623-655 (Pubitemid 32368048)
2. Kanno Y, Levi BZ, Tamura T, Ozato K (2005) Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex. J Interferon Cytokine Res 25:770-779 (Pubitemid 43068488)
3. Savitsky D, Tamura T, Yanai H, Taniguchi T (2010) Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immunother 59:489-510
4. Taro K, Shizuo A (2006) Innate immune recognition of viral infection. Nat Immunol 7:131-137
5. Fujii Y, Shimizu T, Kusumoto M, Kyogoku Y et al (1999) Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences. EMBO J 18:5028-5041 (Pubitemid 29443805)
6. Harada H, Taniguchi T, Tanaka N (1998) The role of interferon regulatory factors in the interferon system and cell growth control. Biochimie 80:641-650 (Pubitemid 29497581)
7. Mamane Y, Heylbroeck C, Genin P, Algarte M et al (1999) Interferon regulatory factors: the next generation. Gene 237:1-14 (Pubitemid 29406192)
8. Takaoka A, Tamura T, Taniguchi T (2008) Interferon regulatory factor family of transcription factors and regulation of oncogen-esis. Cancer Sci 99:467-478 (Pubitemid 351228562)
9. Yoneyama M, Suhara W, Fujita T (2002) Control of IRF-3 activation by phosphorylation. J Interferon Cytokine Res 22:73-76 (Pubitemid 34161284)
10. Wathelet M, Lin CH, Parekh B, Ronco LV et al (1998) Virus infection induces the assembly of coordinately activated transcription factors on the IFN-b enhancer in vivo. Mol Cell 1:507-518 (Pubitemid 128374687)
11. Weaver BK, Kumar KP, Reich NC (1998) Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol Cell Biol 18:1359-1386
12. Yoneyama M, Suhara W, Fukuhara Y, Fukuda M et al (1998) Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J 17:1087-1095 (Pubitemid 28077662)
13. Lin R, Heylbroeck C, Pitha PM, Hiscott J (1998) Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18:2986-2996 (Pubitemid 28183468)
14. Saitoh T, Tun-Kyi A, Ryo A, Yamamoto M, Finn G et al (2006) Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol 7:598-605 (Pubitemid 43797341)
15. Juang YT, Lowther W, Kellum M, Au WC, Lin R, Hiscott J et al (1998) Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc Natl Acad Sci USA 95:9837-9842 (Pubitemid 28415256)
16. Bentz GL, Liu R, Hahn AM, Shackelford J, Pagano JS (2010) Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta. Virology 402:121-128
17. Nissim-Rafinia M, Kerem B (2002) Splicing regulation as a potential genetic modifier. Trends Genet 18:123-127 (Pubitemid 34164637)
18. Karpova AY, Ronco LV, Howley PM (2001) Functional characterization of interferon regulatory factor 3a (IRF-3a), an alternative splice isoform of IRF-3. Mol Cell Biol 21: 4169-4176 (Pubitemid 32565299)
19. Li Y, Hu X, Song Y, Lu Z, Ning T et al (2011) Identification of novel alternative splicing variants of interferon regulatory factor 3. Biochim Biophys Acta 1809:166-175
20. Ren W, Xu HG, Lu C, Jin R, Zou L, Wang Y, Zhou GP (2011) The characterization of two novel IRF-3 transcripts starting from intron 2 of the wild type of IRF-3. Mol Biol Rep 38:4415-4421
21. Xu HG, Ren W, Lu C, Zhou GP (2010) Characterization of the human IRF-3 promoter and its regulation by the transcription factor E2F1. Mol Biol Rep 37:3073-3080
22. Pajares MJ, Ezponda T, Catena R, Calvo A et al (2007) Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol 8:349-357 (Pubitemid 46464532)
23. Bourdon JC, Fernandes K, Murray-Zmijewski F et al (2005) p53 isoforms can regulate p53 transcriptional activity. Genes Dev 19:2122-2137 (Pubitemid 41330315)
24. Jia W, Guo Q (2008) Gene structures and promoter characteristics of interferon regulatory factor 1 (IRF-1), IRF-2 and IRF-7 from snakehead Channa argus. Mol Immunol 45:2419-2428
25. Rosmarin AG, Luo M, Caprio DG, Shang J et al (1998) Sp1 cooperates with the ets transcription factor, GABP, to activate the CD18 (beta2 leukocyte integrin) promoter. J Biol Chem 273: 13097-13103 (Pubitemid 28246876)
26. Parisi F, Wirapati P, Naef F (2007) Identifying synergistic regulation involving c-Myc and sp1 in human tissues. Nucleic Acids Res 35:1098-1107 (Pubitemid 46530360)
27. Canaff L, Zhou X, Hendy GN (2008) The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3. J Biol Chem 283: 13586-13600
28. Suzuki T, Kimura A, Nagai R, Horikoshi M (2000) Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding. Genes Cells 5:29-41 (Pubitemid 30095679)
29. Zhao S, Venkatasubbarao K, Li S, Freeman JW (2003) Requirement of a specific Sp1 site for histone deacetylase-med-iated repression of transforming growth factor beta type II receptor expression in human pancreatic cancer cells. Cancer Res 63:2624-2630 (Pubitemid 36605205)
30. Xu HG, Ren W, Zou L, Wang Y, Jin R, Zhou GP (2012) Tran-scriptional control of human CD2AP expression: the role of Sp1 and Sp3. Mol Biol Rep 39:1479-1486
31. Book McAlexander M, Yu-Lee LY (2001) Sp1 is required for prolactin activation of the interferon regulatory factor-1 gene. Mol Cell Endocrinol 184:135-141
32. Orkin SH (1992) GATA-binding transcription factors in hema-topoietic cells. Blood 80:575-581
33. Matsuyama T, Kimura T, Kitagawa M et al (1993) Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75:83-97 (Pubitemid 23306023)
34. Ogasawara K, Hida S, Azimi N et al (1998) Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391:700-703 (Pubitemid 28113217)